Review



rabbit polyclonal anti survivin af886  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems rabbit polyclonal anti survivin af886
    Rabbit Polyclonal Anti Survivin Af886, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 294 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pmc09862749-245-33-39
    Average 95 stars, based on 294 article reviews
    rabbit polyclonal anti survivin af886 - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: Antitumoral Activity of Leptocarpha rivularis Flower Extracts against Gastric Cancer Cells
    Article Snippet: Mouse monoclonal anti-Caspase 3 (sc-56053), anti-Caspase 9 (sc-133109), anti-PARP-1 (sc-136208), anti-p53 (sc-47698), and anti-HO-1 (sc-136960) antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA); mouse monoclonal anti-β-Actin (A5316) was from Merck-Sigma-Aldrich, and rabbit polyclonal anti-Survivin (AF886) was from R&D systems (Minneapolis, MN, USA).



    Similar Products

    95
    R&D Systems rabbit polyclonal anti survivin af886
    Rabbit Polyclonal Anti Survivin Af886, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pmc09862749-245-33-39
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal anti survivin af886 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems thp1 rnd systems polyclonal rabbit igg af886
    Thp1 Rnd Systems Polyclonal Rabbit Igg Af886, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pm36425763-206-23-24
    Average 95 stars, based on 1 article reviews
    thp1 rnd systems polyclonal rabbit igg af886 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems polyclonal rabbit igg af886 rrid ab 355684
    Polyclonal Rabbit Igg Af886 Rrid Ab 355684, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pmc09678772-5-6-3
    Average 95 stars, based on 1 article reviews
    polyclonal rabbit igg af886 rrid ab 355684 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems rabbit polyclonal anti survivin antibody r d systems
    Rabbit Polyclonal Anti Survivin Antibody R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pmc09515501__DataSheet_1-34-187-192
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal anti survivin antibody r d systems - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems polyclonal rabbit anti human survivin antibody
    Polyclonal Rabbit Anti Human Survivin Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pmc08151203-89-14-20
    Average 95 stars, based on 1 article reviews
    polyclonal rabbit anti human survivin antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems rabbit polyclonal anti survivin
    Rabbit Polyclonal Anti Survivin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pmc08262140-125-7-12
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal anti survivin - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems rabbit polyclonal antibodies for antisurvivin af886
    Rabbit Polyclonal Antibodies For Antisurvivin Af886, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pm29207153-69-29-35
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal antibodies for antisurvivin af886 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems rabbit anti human survivin polyclonal antibody
    (A) Linear regression model for <t>Survivin</t> and RPRM in 237 cases for which Survivin and RPRM counts were greater than zero and p53 status was available. log 2( Survivin ) = 8.98 − 0.20 * log 2( RPRM ) (B) Linear regression models for Survivin and RPRM according to p53 status. For p53-mutated samples (n=116, red regression line): log 2( Survivin ) = 9.02106 − 0.10055 * log 2( RPRM ) For wild-type p53 samples (n=121, blue regression line): log 2( Survivin ) = 8.87772 − 0.26013 * log 2( RPRM ).
    Rabbit Anti Human Survivin Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pmc05849179-153-40-47
    Average 95 stars, based on 1 article reviews
    rabbit anti human survivin polyclonal antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems anti survivin rabbit polyclonal antibody
    Figure 1. The <t>survivin</t> expression in blood and synovial tissues from RA and OA patients. (a) The serum survivin expression levels were analyzed using an ELISA. (RA, 22 cases; controls, 16 cases) (mean RA, 19.5 pg/ml vs. controls, 7.7 pg/ml; p = 0.044). An age- and sex-matched control group consisted of OA and healthy controls (RA, 58.8 ± 15.6 years old; controls, 53.9 ± 19.8 years old; p = 0.404). t-test, *p < 0.05. (b) The survivin expressions in RA and OA synovial tissues were analyzed using IHC (survivin: red, upper sections x40, lower sections x20). The data shown are representative of the samples. Arrows indicate the endothelium of synovia. (c–f) Dual staining in immunohistochemistry for RA synovial tissues. Red pigment and arrows indicate the expression of each lineage marker (CD55; a marker of FLS, CD4; a marker of CD4+ T lymphocytes, CD8; a marker of CD8+ T lymphocytes, MPO (myeloperoxidase); a marker of neutrophil). Green pigment indicates survivin. (x40)
    Anti Survivin Rabbit Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pm25997820-234-18-22
    Average 95 stars, based on 1 article reviews
    anti survivin rabbit polyclonal antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems anti human survivin polyclonal rabbit antibody
    Figure 1. The <t>survivin</t> expression in blood and synovial tissues from RA and OA patients. (a) The serum survivin expression levels were analyzed using an ELISA. (RA, 22 cases; controls, 16 cases) (mean RA, 19.5 pg/ml vs. controls, 7.7 pg/ml; p = 0.044). An age- and sex-matched control group consisted of OA and healthy controls (RA, 58.8 ± 15.6 years old; controls, 53.9 ± 19.8 years old; p = 0.404). t-test, *p < 0.05. (b) The survivin expressions in RA and OA synovial tissues were analyzed using IHC (survivin: red, upper sections x40, lower sections x20). The data shown are representative of the samples. Arrows indicate the endothelium of synovia. (c–f) Dual staining in immunohistochemistry for RA synovial tissues. Red pigment and arrows indicate the expression of each lineage marker (CD55; a marker of FLS, CD4; a marker of CD4+ T lymphocytes, CD8; a marker of CD8+ T lymphocytes, MPO (myeloperoxidase); a marker of neutrophil). Green pigment indicates survivin. (x40)
    Anti Human Survivin Polyclonal Rabbit Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+af886/Human+Survivin+Antibody/pmc03947151-81-10-16
    Average 95 stars, based on 1 article reviews
    anti human survivin polyclonal rabbit antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    (A) Linear regression model for Survivin and RPRM in 237 cases for which Survivin and RPRM counts were greater than zero and p53 status was available. log 2( Survivin ) = 8.98 − 0.20 * log 2( RPRM ) (B) Linear regression models for Survivin and RPRM according to p53 status. For p53-mutated samples (n=116, red regression line): log 2( Survivin ) = 9.02106 − 0.10055 * log 2( RPRM ) For wild-type p53 samples (n=121, blue regression line): log 2( Survivin ) = 8.87772 − 0.26013 * log 2( RPRM ).

    Journal: Oncotarget

    Article Title: Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer

    doi: 10.18632/oncotarget.24402

    Figure Lengend Snippet: (A) Linear regression model for Survivin and RPRM in 237 cases for which Survivin and RPRM counts were greater than zero and p53 status was available. log 2( Survivin ) = 8.98 − 0.20 * log 2( RPRM ) (B) Linear regression models for Survivin and RPRM according to p53 status. For p53-mutated samples (n=116, red regression line): log 2( Survivin ) = 9.02106 − 0.10055 * log 2( RPRM ) For wild-type p53 samples (n=121, blue regression line): log 2( Survivin ) = 8.87772 − 0.26013 * log 2( RPRM ).

    Article Snippet: The membranes were blocked as described previously [ ] and then probed with rabbit anti-beta-actin polyclonal antibody (1:5000, A5060, Sigma, St Louis, MO, US) as a loading control, mouse anti-FLAG monoclonal antibody (1:2000, F3165, Sigma, St Louis, MO, US) or rabbit anti-human Survivin polyclonal antibody (1:3000, AF886, R&D Systems, Minneapolis, MN, USA).

    Techniques:

    Survivin and RPRM expression levels were evaluated by RT-qPCR in biopsies of tissue samples and normalized to RPS13 mRNA expression levels. Statistically significant differences between RPRM expression in NTAM and tumor samples ( ** p≤ 0.001), as well as for Survivin expression in NTAM and tumor samples ( **** p≤ 0.0001) are indicated (means ± SEM; n = 13 for each sample type).

    Journal: Oncotarget

    Article Title: Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer

    doi: 10.18632/oncotarget.24402

    Figure Lengend Snippet: Survivin and RPRM expression levels were evaluated by RT-qPCR in biopsies of tissue samples and normalized to RPS13 mRNA expression levels. Statistically significant differences between RPRM expression in NTAM and tumor samples ( ** p≤ 0.001), as well as for Survivin expression in NTAM and tumor samples ( **** p≤ 0.0001) are indicated (means ± SEM; n = 13 for each sample type).

    Article Snippet: The membranes were blocked as described previously [ ] and then probed with rabbit anti-beta-actin polyclonal antibody (1:5000, A5060, Sigma, St Louis, MO, US) as a loading control, mouse anti-FLAG monoclonal antibody (1:2000, F3165, Sigma, St Louis, MO, US) or rabbit anti-human Survivin polyclonal antibody (1:3000, AF886, R&D Systems, Minneapolis, MN, USA).

    Techniques: Expressing, Quantitative RT-PCR

    Survivin and RPRM mRNA expression levels were evaluated by RT-qPCR. Results for (A) SNU-1, (B) AGS and (C) NCI-N87 cells 24 h after transfection with pEGFP-Survivin or pEGFP-empty are shown after normalizing to β-actin mRNA expression levels used as a housekeeping control gene. Note that AGS cells were treated with 5-Aza-2’-deoxycytidine (1 mM) for 24 h prior to transfection. Expression levels in non-transfected cells were used to standardize each experiment (control). Statistically significant differences compared to cells transfected with pEGFP-Survivin or empty vector are shown (means ± SEM; n = 4; Mann-Whitney test; * p < 0.05).

    Journal: Oncotarget

    Article Title: Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer

    doi: 10.18632/oncotarget.24402

    Figure Lengend Snippet: Survivin and RPRM mRNA expression levels were evaluated by RT-qPCR. Results for (A) SNU-1, (B) AGS and (C) NCI-N87 cells 24 h after transfection with pEGFP-Survivin or pEGFP-empty are shown after normalizing to β-actin mRNA expression levels used as a housekeeping control gene. Note that AGS cells were treated with 5-Aza-2’-deoxycytidine (1 mM) for 24 h prior to transfection. Expression levels in non-transfected cells were used to standardize each experiment (control). Statistically significant differences compared to cells transfected with pEGFP-Survivin or empty vector are shown (means ± SEM; n = 4; Mann-Whitney test; * p < 0.05).

    Article Snippet: The membranes were blocked as described previously [ ] and then probed with rabbit anti-beta-actin polyclonal antibody (1:5000, A5060, Sigma, St Louis, MO, US) as a loading control, mouse anti-FLAG monoclonal antibody (1:2000, F3165, Sigma, St Louis, MO, US) or rabbit anti-human Survivin polyclonal antibody (1:3000, AF886, R&D Systems, Minneapolis, MN, USA).

    Techniques: Expressing, Quantitative RT-PCR, Transfection, Control, Plasmid Preparation, MANN-WHITNEY

    Survivin and RPRM expression levels were evaluated by RT-qPCR in (A) SNU-1, (B) AGS and (C) NCI-N87 cells 24 h after transfection with either pCMV6-empty or pCMV6-RPRM. Values were normalized to β-actin mRNA expression levels used as a housekeeping gene. Expression levels in non-transfected cells were used to standardize each experiment (control). Protein levels assessed by Western blot analysis for (D) SNU-1, (E) AGS and (F) NCI-N87 cells 24 h after transfection with empty vector or pCMV6-RPRM normalized to β-actin are shown. Statistically significant differences compared to cells transfected with pCMV6-RPRM or empty plasmid are indicated (means ± SEM; n = 4; Mann-Whitney test; * p ≤ 0.05).

    Journal: Oncotarget

    Article Title: Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer

    doi: 10.18632/oncotarget.24402

    Figure Lengend Snippet: Survivin and RPRM expression levels were evaluated by RT-qPCR in (A) SNU-1, (B) AGS and (C) NCI-N87 cells 24 h after transfection with either pCMV6-empty or pCMV6-RPRM. Values were normalized to β-actin mRNA expression levels used as a housekeeping gene. Expression levels in non-transfected cells were used to standardize each experiment (control). Protein levels assessed by Western blot analysis for (D) SNU-1, (E) AGS and (F) NCI-N87 cells 24 h after transfection with empty vector or pCMV6-RPRM normalized to β-actin are shown. Statistically significant differences compared to cells transfected with pCMV6-RPRM or empty plasmid are indicated (means ± SEM; n = 4; Mann-Whitney test; * p ≤ 0.05).

    Article Snippet: The membranes were blocked as described previously [ ] and then probed with rabbit anti-beta-actin polyclonal antibody (1:5000, A5060, Sigma, St Louis, MO, US) as a loading control, mouse anti-FLAG monoclonal antibody (1:2000, F3165, Sigma, St Louis, MO, US) or rabbit anti-human Survivin polyclonal antibody (1:3000, AF886, R&D Systems, Minneapolis, MN, USA).

    Techniques: Expressing, Quantitative RT-PCR, Transfection, Gene Expression, Control, Western Blot, Plasmid Preparation, MANN-WHITNEY

    Survivin and RPRM expression levels evaluated by immunohistochemistry on a tissue microarray of gastric cancer cases for clinicopathological correlations. Survivin and RPRM presence in cells is revealed as brown staining. All samples were counterstained with hematoxylin (blue nuclei). The original magnification for images (A-D) and (a-d) was 100x (image at bottom right) and 400x for images (A’-D’) and (a’-d’) . The scale bar setting for all images was 100 μm. Survivin and RPRM protein levels were semi-quantified using the median expression method (see methods for details) in TMA sections. Two cases did not show mutual Survivin and RPRM exclusion, being negative (A-a) or positive (D-d) for both genes. B-b and C-c show mutual exclusion for Survivin and RPRM, being either Survivin(-)/RPRM(+) or Survivin(+)/RPRM(−).

    Journal: Oncotarget

    Article Title: Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer

    doi: 10.18632/oncotarget.24402

    Figure Lengend Snippet: Survivin and RPRM expression levels evaluated by immunohistochemistry on a tissue microarray of gastric cancer cases for clinicopathological correlations. Survivin and RPRM presence in cells is revealed as brown staining. All samples were counterstained with hematoxylin (blue nuclei). The original magnification for images (A-D) and (a-d) was 100x (image at bottom right) and 400x for images (A’-D’) and (a’-d’) . The scale bar setting for all images was 100 μm. Survivin and RPRM protein levels were semi-quantified using the median expression method (see methods for details) in TMA sections. Two cases did not show mutual Survivin and RPRM exclusion, being negative (A-a) or positive (D-d) for both genes. B-b and C-c show mutual exclusion for Survivin and RPRM, being either Survivin(-)/RPRM(+) or Survivin(+)/RPRM(−).

    Article Snippet: The membranes were blocked as described previously [ ] and then probed with rabbit anti-beta-actin polyclonal antibody (1:5000, A5060, Sigma, St Louis, MO, US) as a loading control, mouse anti-FLAG monoclonal antibody (1:2000, F3165, Sigma, St Louis, MO, US) or rabbit anti-human Survivin polyclonal antibody (1:3000, AF886, R&D Systems, Minneapolis, MN, USA).

    Techniques: Expressing, Immunohistochemistry, Microarray, Staining

    Results are shown comparing 21 Survivin positive/RPRM positive and 17 Survivin positive/RPRM negative cases. Overall survival analysis by Kaplan-Meier estimation considering Survivin and RPRM protein expression after correction for age and sex. A worse prognosis among Survivin-positive patients is observed in RPRM negative cases (p=0.047, Long Rank Test) (HR=0.32; 95%IC: 0.11-0.97; p=0.044).

    Journal: Oncotarget

    Article Title: Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer

    doi: 10.18632/oncotarget.24402

    Figure Lengend Snippet: Results are shown comparing 21 Survivin positive/RPRM positive and 17 Survivin positive/RPRM negative cases. Overall survival analysis by Kaplan-Meier estimation considering Survivin and RPRM protein expression after correction for age and sex. A worse prognosis among Survivin-positive patients is observed in RPRM negative cases (p=0.047, Long Rank Test) (HR=0.32; 95%IC: 0.11-0.97; p=0.044).

    Article Snippet: The membranes were blocked as described previously [ ] and then probed with rabbit anti-beta-actin polyclonal antibody (1:5000, A5060, Sigma, St Louis, MO, US) as a loading control, mouse anti-FLAG monoclonal antibody (1:2000, F3165, Sigma, St Louis, MO, US) or rabbit anti-human Survivin polyclonal antibody (1:3000, AF886, R&D Systems, Minneapolis, MN, USA).

    Techniques: Expressing

    Figure 1. The survivin expression in blood and synovial tissues from RA and OA patients. (a) The serum survivin expression levels were analyzed using an ELISA. (RA, 22 cases; controls, 16 cases) (mean RA, 19.5 pg/ml vs. controls, 7.7 pg/ml; p = 0.044). An age- and sex-matched control group consisted of OA and healthy controls (RA, 58.8 ± 15.6 years old; controls, 53.9 ± 19.8 years old; p = 0.404). t-test, *p < 0.05. (b) The survivin expressions in RA and OA synovial tissues were analyzed using IHC (survivin: red, upper sections x40, lower sections x20). The data shown are representative of the samples. Arrows indicate the endothelium of synovia. (c–f) Dual staining in immunohistochemistry for RA synovial tissues. Red pigment and arrows indicate the expression of each lineage marker (CD55; a marker of FLS, CD4; a marker of CD4+ T lymphocytes, CD8; a marker of CD8+ T lymphocytes, MPO (myeloperoxidase); a marker of neutrophil). Green pigment indicates survivin. (x40)

    Journal: Scientific reports

    Article Title: The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.

    doi: 10.1038/srep09795

    Figure Lengend Snippet: Figure 1. The survivin expression in blood and synovial tissues from RA and OA patients. (a) The serum survivin expression levels were analyzed using an ELISA. (RA, 22 cases; controls, 16 cases) (mean RA, 19.5 pg/ml vs. controls, 7.7 pg/ml; p = 0.044). An age- and sex-matched control group consisted of OA and healthy controls (RA, 58.8 ± 15.6 years old; controls, 53.9 ± 19.8 years old; p = 0.404). t-test, *p < 0.05. (b) The survivin expressions in RA and OA synovial tissues were analyzed using IHC (survivin: red, upper sections x40, lower sections x20). The data shown are representative of the samples. Arrows indicate the endothelium of synovia. (c–f) Dual staining in immunohistochemistry for RA synovial tissues. Red pigment and arrows indicate the expression of each lineage marker (CD55; a marker of FLS, CD4; a marker of CD4+ T lymphocytes, CD8; a marker of CD8+ T lymphocytes, MPO (myeloperoxidase); a marker of neutrophil). Green pigment indicates survivin. (x40)

    Article Snippet: For the immunohistochemistry (IHC) studies, Western blot analysis and enzyme-linked immunosorbent assay (ELISA), we purchased the following antibodies: anti-survivin rabbit polyclonal antibody (R&D systems), anti-survivin rabbit monoclonal antibody (Cell Signaling Technology, clone.

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Control, Staining, Immunohistochemistry, Marker

    Figure 2. The expression of survivin splice variants in RA and OA synovial tissues.(a) The survivin pre-mRNA generates some mature mRNA transcripts (splice variants) which result from alternative splice. Arrows indicate the stop codon. (b) RT-PCR of whole synovial tissues showed the expression of survivin splice variants (n = 9 different RA patients, n = 6 different OA patients and the HL-60 cell line). The forward primer was located in Exon 2 and the reverse primer was located in Exon 4. Forty cycles of PCR were performed. The data shown are representative of the samples and cropped image was used. The gels have been run under the same experimental conditions. (c,d) The relative expression levels determined by real-time PCR with the TaqMan method. The relative expression levels were corrected based on the expression level of HPRT. (c) Whole synovial tissues (n = 9 from different RA patients, n = 6 from different OA patients) (RA, 68.4 ± 7.2 years old; OA, 74.1 ± 7.9 years old; t-test, p = 0.183). The Dunnett method, ∗p < 0.05 (WT; p < 0.01, 2B; p = 0.018 and Δ Ex3; p > 0.05, respectively). (d) Separated cells from the synovium from different RA patients (n = 3). The CD55+ cells indicate RA-FLS (CD3–CD14–CD16–CD19–CD20–CD56–CD45–CD55+), the CD19+ cells indicate B cells (CD45+CD19+), and the CD4+ cells indicate T cells (CD45+CD4+). The results are the Means ± SEM. (e) The results of the Western blot analysis to confirm whether anti-survivin splice variant antibodies react with the three types of GST-fusion survivin proteins. The anti-survivin-2B (chicken and rabbit polyclonal antibodies) and anti-survivin-Δ Ex3 (chicken polyclonal antibodies) antibodies recognized the GST fusion human survivin variants corresponding to each antibody. The anti-survivin antibodies (rabbit monoclonal and polyclonal antibodies) reacted against all three GST- fusion splice variants. The cropped blots were used in the figure. (f–g) Immunohistochemistrical (IHC) staining of survivin-2B and -Δ Ex3 in RA and OA synovial tissues (red, x40, x20). The primary antibodies against survivin-2B and -Δ Ex3 were used. (h–l) The dual IHC staining of lineage markers (red) and survivin-2B (green) in RA synovial tissues (x40). Arrows indicate lineage marker-positive cells. (h) CD55 and survivin-2B. (i) CD4 and survivin-2B. (j) CD8 and survivin-2B. (k) MPO and survivin-2B. (l) CD19 and survivin-2B.

    Journal: Scientific reports

    Article Title: The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.

    doi: 10.1038/srep09795

    Figure Lengend Snippet: Figure 2. The expression of survivin splice variants in RA and OA synovial tissues.(a) The survivin pre-mRNA generates some mature mRNA transcripts (splice variants) which result from alternative splice. Arrows indicate the stop codon. (b) RT-PCR of whole synovial tissues showed the expression of survivin splice variants (n = 9 different RA patients, n = 6 different OA patients and the HL-60 cell line). The forward primer was located in Exon 2 and the reverse primer was located in Exon 4. Forty cycles of PCR were performed. The data shown are representative of the samples and cropped image was used. The gels have been run under the same experimental conditions. (c,d) The relative expression levels determined by real-time PCR with the TaqMan method. The relative expression levels were corrected based on the expression level of HPRT. (c) Whole synovial tissues (n = 9 from different RA patients, n = 6 from different OA patients) (RA, 68.4 ± 7.2 years old; OA, 74.1 ± 7.9 years old; t-test, p = 0.183). The Dunnett method, ∗p < 0.05 (WT; p < 0.01, 2B; p = 0.018 and Δ Ex3; p > 0.05, respectively). (d) Separated cells from the synovium from different RA patients (n = 3). The CD55+ cells indicate RA-FLS (CD3–CD14–CD16–CD19–CD20–CD56–CD45–CD55+), the CD19+ cells indicate B cells (CD45+CD19+), and the CD4+ cells indicate T cells (CD45+CD4+). The results are the Means ± SEM. (e) The results of the Western blot analysis to confirm whether anti-survivin splice variant antibodies react with the three types of GST-fusion survivin proteins. The anti-survivin-2B (chicken and rabbit polyclonal antibodies) and anti-survivin-Δ Ex3 (chicken polyclonal antibodies) antibodies recognized the GST fusion human survivin variants corresponding to each antibody. The anti-survivin antibodies (rabbit monoclonal and polyclonal antibodies) reacted against all three GST- fusion splice variants. The cropped blots were used in the figure. (f–g) Immunohistochemistrical (IHC) staining of survivin-2B and -Δ Ex3 in RA and OA synovial tissues (red, x40, x20). The primary antibodies against survivin-2B and -Δ Ex3 were used. (h–l) The dual IHC staining of lineage markers (red) and survivin-2B (green) in RA synovial tissues (x40). Arrows indicate lineage marker-positive cells. (h) CD55 and survivin-2B. (i) CD4 and survivin-2B. (j) CD8 and survivin-2B. (k) MPO and survivin-2B. (l) CD19 and survivin-2B.

    Article Snippet: For the immunohistochemistry (IHC) studies, Western blot analysis and enzyme-linked immunosorbent assay (ELISA), we purchased the following antibodies: anti-survivin rabbit polyclonal antibody (R&D systems), anti-survivin rabbit monoclonal antibody (Cell Signaling Technology, clone.

    Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Real-time Polymerase Chain Reaction, Western Blot, Variant Assay, Immunohistochemistry, Marker

    Figure 3. The expression levels of survivin (-WT and -2B) in RA-FLS are upregulated by PDGF, but not by IL-1β, TNF-α or leptin.(a) Cultured primary synoviocytes from RA patients were analyzed for survivin-WT and -2B expressions using a Western blot analysis. The survivin expression levels in the adherent cultured primary synoviocytes decreased with the cells passages. The cropped blots were used in the figure. (b) PDGF increased the survivin-WT and -2B expression levels, as indicated by a Western blot analysis. The cropped blots were used in the figure. (c–g) RA-FLS (n = 3 from different RA individuals) were cultured in the presence of (c) PDGF (10 ng/ml), (e) IL-1β (1 ng/ml), (f) TNF-α (20 ng/ml) or (g) leptin (1000 nM) for 24 to 48 hours and (d) PDGF (from 0.1 to 10.0 ng/ml) for 48 hours, after serum starvation (0.1%FBS/DMEM) for 24 hours. The time- and dose-dependent relative expression levels of survivin-WT and -2B were analyzed by real-time PCR. The relative expression levels were corrected based on the level of HPRT. Adherent FLS were used for experiments (without (a)) at passages 3 through 6. The results are the Means ± SEM (standard error of the mean). The Dunnett method, ∗∗p < 0.01, ∗p < 0.05.

    Journal: Scientific reports

    Article Title: The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.

    doi: 10.1038/srep09795

    Figure Lengend Snippet: Figure 3. The expression levels of survivin (-WT and -2B) in RA-FLS are upregulated by PDGF, but not by IL-1β, TNF-α or leptin.(a) Cultured primary synoviocytes from RA patients were analyzed for survivin-WT and -2B expressions using a Western blot analysis. The survivin expression levels in the adherent cultured primary synoviocytes decreased with the cells passages. The cropped blots were used in the figure. (b) PDGF increased the survivin-WT and -2B expression levels, as indicated by a Western blot analysis. The cropped blots were used in the figure. (c–g) RA-FLS (n = 3 from different RA individuals) were cultured in the presence of (c) PDGF (10 ng/ml), (e) IL-1β (1 ng/ml), (f) TNF-α (20 ng/ml) or (g) leptin (1000 nM) for 24 to 48 hours and (d) PDGF (from 0.1 to 10.0 ng/ml) for 48 hours, after serum starvation (0.1%FBS/DMEM) for 24 hours. The time- and dose-dependent relative expression levels of survivin-WT and -2B were analyzed by real-time PCR. The relative expression levels were corrected based on the level of HPRT. Adherent FLS were used for experiments (without (a)) at passages 3 through 6. The results are the Means ± SEM (standard error of the mean). The Dunnett method, ∗∗p < 0.01, ∗p < 0.05.

    Article Snippet: For the immunohistochemistry (IHC) studies, Western blot analysis and enzyme-linked immunosorbent assay (ELISA), we purchased the following antibodies: anti-survivin rabbit polyclonal antibody (R&D systems), anti-survivin rabbit monoclonal antibody (Cell Signaling Technology, clone.

    Techniques: Expressing, Cell Culture, Western Blot, Real-time Polymerase Chain Reaction

    Figure 4. Functional analyses using siRNA against survivin-2B in PDGF treated RA-FLS. (a) The calcein assay for cell proliferation was performed. PDGF increased the number of RA-FLS at 36hours (n = 4, p < 0.05). (b–i) RA-FLS treated with PDGF (10 ng/ml) and transfected with siRNA. (b,c) The siRNA birc5 (all survivin isoform silencer) decreased the expression levels of both survivin-WT and -2B. The siRNA 2B decreased the expression level of survivin-2B and had little influence on the survivin-WT expression. (b) The results of real-time PCR for siRNA-induced survivin silencing (n = 3). (c) The results of Western blot analyses for siRNA-induced survivin silencing with siRNA birc5 (upper) or siRNA 2B (lower). The cropped blots were used in the figure. (d) The viability of RA-FLS transfected with siRNA birc5 (left, n = 5) or siRNA 2B (right, n = 6) at 48 hours as determined using the calcein assay. (e,f) Measurement of Ki-67-positive RA-FLS transfected with siRNA at 48hours (n = 3). The positive rate was calculated as the number of Ki-67- positive cells among the total RA-FLS. (e) FACS plots for siRNA control (left) and siRNA 2B (right). (g–i) The annexin V and PI analysis for RA-FLS transfected with siRNA at 48hours (n = 4). H2O2 stimulation (0.1 mM) was performed for 3 hours before the analysis. (g) FACS plots for siRNA control (left) and siRNA 2B (right). (h) The percentage of live cells was calculated as the number of annexin V- and PI-double negative cells among the total RA-FLS. (i) The percentage of apoptotic cells was calculated as the number of annexin V-positive and PI-negative cells among the total RA-FLS. The results are the Means ± SEM. t-test

    Journal: Scientific reports

    Article Title: The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.

    doi: 10.1038/srep09795

    Figure Lengend Snippet: Figure 4. Functional analyses using siRNA against survivin-2B in PDGF treated RA-FLS. (a) The calcein assay for cell proliferation was performed. PDGF increased the number of RA-FLS at 36hours (n = 4, p < 0.05). (b–i) RA-FLS treated with PDGF (10 ng/ml) and transfected with siRNA. (b,c) The siRNA birc5 (all survivin isoform silencer) decreased the expression levels of both survivin-WT and -2B. The siRNA 2B decreased the expression level of survivin-2B and had little influence on the survivin-WT expression. (b) The results of real-time PCR for siRNA-induced survivin silencing (n = 3). (c) The results of Western blot analyses for siRNA-induced survivin silencing with siRNA birc5 (upper) or siRNA 2B (lower). The cropped blots were used in the figure. (d) The viability of RA-FLS transfected with siRNA birc5 (left, n = 5) or siRNA 2B (right, n = 6) at 48 hours as determined using the calcein assay. (e,f) Measurement of Ki-67-positive RA-FLS transfected with siRNA at 48hours (n = 3). The positive rate was calculated as the number of Ki-67- positive cells among the total RA-FLS. (e) FACS plots for siRNA control (left) and siRNA 2B (right). (g–i) The annexin V and PI analysis for RA-FLS transfected with siRNA at 48hours (n = 4). H2O2 stimulation (0.1 mM) was performed for 3 hours before the analysis. (g) FACS plots for siRNA control (left) and siRNA 2B (right). (h) The percentage of live cells was calculated as the number of annexin V- and PI-double negative cells among the total RA-FLS. (i) The percentage of apoptotic cells was calculated as the number of annexin V-positive and PI-negative cells among the total RA-FLS. The results are the Means ± SEM. t-test

    Article Snippet: For the immunohistochemistry (IHC) studies, Western blot analysis and enzyme-linked immunosorbent assay (ELISA), we purchased the following antibodies: anti-survivin rabbit polyclonal antibody (R&D systems), anti-survivin rabbit monoclonal antibody (Cell Signaling Technology, clone.

    Techniques: Functional Assay, Transfection, Expressing, Real-time Polymerase Chain Reaction, Western Blot, Control

    Figure 5. Functional analyses of survivin-2B-overexpressing RA-FLS.The IVT mRNA (mock and survivin-2B) transfection was used for overexpression experiments for RA-FLS. (a) A Western blot analysis showed that survivin-2B mRNA expressed survivin-2B protein. The cropped blots were used in the figure. (b) The viability of RA-FLS transfected with mRNA (n = 6) at 36hours as determined using the calcein assay. (c,d) Measurement of the Ki-67-positive RA-FLS transfected with mRNA at 48hours (n = 4). The positive rate was calculated as the number of Ki-67-positive cells among the total RA-FLS. (d) FACS plot for mock mRNA (left) and survivin-2B mRNA (right). (e–g) The annexin V and PI analysis for RA-FLS transfected with mRNA at 24hours (n = 4). H2O2 stimulation (0.1 mM) was performed for 3hours before the analysis. (e) The percentage of live cells was calculated as the number of annexin V- and PI-double negative cells among the total RA-FLS. (f) The percentage of apoptotic cells was calculated as the number of Annexin V-positive and PI-negative cells among the total RA-FLS. (g) FACS plot for mock mRNA (left) and survivin-2B mRNA (right). The results are the Means ± SEM. t-test ∗p < 0.05, ∗∗ p < 0.01.

    Journal: Scientific reports

    Article Title: The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.

    doi: 10.1038/srep09795

    Figure Lengend Snippet: Figure 5. Functional analyses of survivin-2B-overexpressing RA-FLS.The IVT mRNA (mock and survivin-2B) transfection was used for overexpression experiments for RA-FLS. (a) A Western blot analysis showed that survivin-2B mRNA expressed survivin-2B protein. The cropped blots were used in the figure. (b) The viability of RA-FLS transfected with mRNA (n = 6) at 36hours as determined using the calcein assay. (c,d) Measurement of the Ki-67-positive RA-FLS transfected with mRNA at 48hours (n = 4). The positive rate was calculated as the number of Ki-67-positive cells among the total RA-FLS. (d) FACS plot for mock mRNA (left) and survivin-2B mRNA (right). (e–g) The annexin V and PI analysis for RA-FLS transfected with mRNA at 24hours (n = 4). H2O2 stimulation (0.1 mM) was performed for 3hours before the analysis. (e) The percentage of live cells was calculated as the number of annexin V- and PI-double negative cells among the total RA-FLS. (f) The percentage of apoptotic cells was calculated as the number of Annexin V-positive and PI-negative cells among the total RA-FLS. (g) FACS plot for mock mRNA (left) and survivin-2B mRNA (right). The results are the Means ± SEM. t-test ∗p < 0.05, ∗∗ p < 0.01.

    Article Snippet: For the immunohistochemistry (IHC) studies, Western blot analysis and enzyme-linked immunosorbent assay (ELISA), we purchased the following antibodies: anti-survivin rabbit polyclonal antibody (R&D systems), anti-survivin rabbit monoclonal antibody (Cell Signaling Technology, clone.

    Techniques: Functional Assay, Transfection, Over Expression, Western Blot

    Figure 6. The serum expression levels of survivin-2B in RA patients determined using an ELISA. (a) We collected serum samples from 35 RA patients and 21 age- and sex- matched controls (healthy controls and OA patients), and measured the serum survivin-2B levels with an ELISA (mean RA, 18.7 ng/ml vs. controls, 4.7 ng/ml; p = 0.049) (RA, 64.7 ± 11.4 years old; controls, 59.6 ± 18.0 years old; p = 0.250). The gray lines indicate the median of survivin-2B level in each group. (b) We compared the DAS28-ESR between the survivin-2B high RA group (n = 18) and the survivin-2B low RA group (n = 21) (mean RA, 4.64 vs. controls, 3.64; p = 0.037). t-test, ∗p < 0.05.

    Journal: Scientific reports

    Article Title: The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.

    doi: 10.1038/srep09795

    Figure Lengend Snippet: Figure 6. The serum expression levels of survivin-2B in RA patients determined using an ELISA. (a) We collected serum samples from 35 RA patients and 21 age- and sex- matched controls (healthy controls and OA patients), and measured the serum survivin-2B levels with an ELISA (mean RA, 18.7 ng/ml vs. controls, 4.7 ng/ml; p = 0.049) (RA, 64.7 ± 11.4 years old; controls, 59.6 ± 18.0 years old; p = 0.250). The gray lines indicate the median of survivin-2B level in each group. (b) We compared the DAS28-ESR between the survivin-2B high RA group (n = 18) and the survivin-2B low RA group (n = 21) (mean RA, 4.64 vs. controls, 3.64; p = 0.037). t-test, ∗p < 0.05.

    Article Snippet: For the immunohistochemistry (IHC) studies, Western blot analysis and enzyme-linked immunosorbent assay (ELISA), we purchased the following antibodies: anti-survivin rabbit polyclonal antibody (R&D systems), anti-survivin rabbit monoclonal antibody (Cell Signaling Technology, clone.

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay